Top Stories
Segmed's library spans more than 2800 healthcare partner sites and 150 million imaging studies.
With the help of the PrecivityAD2 blood test results, primary care physicians were 93% accurate in diagnosing Alzheimer’s disease.
Moneta said 71% to 94% of Medicare patients improved across four measures in a model designed to reach rural neurology deserts, with therapist-rated outcomes meeting or exceeding in-person benchmarks.
The drugmaker will use Chai-3 to discover therapeutic antibodies.
The companies will co-develop a CNS candidate built around a newly-identified mechanism, sharing responsibilities from discovery through commercialisation.
Conference News
CLEVELAND, July 14, 2026 (GLOBE NEWSWIRE) -- Pain medicine physicians from across the U.S. will continue to expand their knowledge on the broad applications for the SPRINT PNS System at the American S...
The Consortium for Biomedical Research and Artificial Intelligence in Neurodegeneration (C-BRAIN) has launched three open-source AI tools to accelerate research into Alzheimer’s and other neurodegener...
LONDON, July 13, 2026 (GLOBE NEWSWIRE) -- The same brain training shown in the past nine months to reduce the incidence of Alzheimer’s in the ACTIVE Study and to rejuvenate the production of the brain...
OXFORD, United Kingdom, July 13, 2026 (GLOBE NEWSWIRE) -- Oxford Brain Diagnostics (OBD), a leader in MRI-based measurement of brain health and neurodegenerative disease, today announced the presentat...
Presence builds on 205 original research articles documenting ALZpath's antibody use across Alzheimer's blood-based biomarker researchCARLSBAD, Calif., July 13, 2026 /PRNewswire/ -- ALZpath, Inc., a l...
